Hyundai Pharmaceutical Co., Ltd. (004310.KS)
KRW 3710.0
(-2.62%)
KRW 3710.0
(-2.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.54 Billion | 11.62 Billion | 5.13 Billion | 10.8 Billion | 5.71 Billion | 3.39 Billion |
| Net Income | 6.62 Billion | -164.58 Million | -3.17 Billion | 2.18 Billion | 1.21 Billion | -2.1 Billion |
| Depreciation & Amortization | 3.3 Billion | 3.29 Billion | 3.97 Billion | 4.11 Billion | 3.51 Billion | 3.19 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -28.23 Billion | 1.74 Billion | -600.18 Million | 2.78 Billion | -3.04 Billion | 1.71 Billion |
| Other non-cash items | 13.76 Billion | 6.74 Billion | 4.92 Billion | 1.71 Billion | 4.03 Billion | 588.14 Million |
| Investing Cash Flow | -3.08 Billion | -9.99 Billion | -27.74 Million | -12.38 Billion | -2.72 Billion | -6.04 Billion |
| Investments in PPE | -6.1 Billion | -6.58 Billion | -6.8 Billion | -6.4 Billion | -2.35 Billion | -3.23 Billion |
| Acquisitions | 793.11 Million | 6.55 Million | -5.48 Billion | -5.78 Billion | 4.3 Million | 1.23 Billion |
| Investment purchases | -3.97 Billion | -3.74 Billion | -10 Billion | -6.48 Billion | -373.1 Million | -3.23 Billion |
| Sales/Maturities of investments | 4.49 Billion | 291.48 Million | 16.74 Billion | 427.26 Million | -4.3 Million | 340 Million |
| Other Investing Activities | 1.7 Billion | 35 Million | 5.52 Billion | 5.86 Billion | 4.3 Million | -1.15 Billion |
| Financing Cash Flow | -6.42 Billion | 7 Billion | 3.25 Billion | 7.45 Billion | -2.94 Billion | 1.77 Billion |
| Debt repayment | -8 Billion | -10 Billion | -10 Billion | -21 Billion | -21 Billion | -29.45 Billion |
| Dividends payments | -826.19 Million | -836.05 Million | -1.18 Billion | -1.21 Billion | -1.23 Billion | -1.17 Billion |
| Common Stock Repurchased | -3.8 Billion | -1.52 Billion | - | -279.3 Million | -1.71 Billion | -3.19 Billion |
| Common Stock Issuance | - | -10 Billion | - | 6.52 Billion | - | 14.59 Billion |
| Other Financing Activities | 6.2 Billion | 29.36 Billion | 14.43 Billion | 23.41 Billion | 21 Billion | 21 Billion |
| Accounts receivables | 3 Billion | -840.24 Million | 1.07 Billion | 2.97 Billion | -1.43 Billion | -331.19 Million |
| Accounts payables | -6.2 Billion | 1.28 Billion | 3.85 Billion | 1.15 Billion | -1.4 Billion | 1.91 Billion |
| Inventory | -3.14 Billion | -2.36 Billion | -4.95 Billion | 356.92 Million | -379.49 Million | -320.95 Million |
| Other working capital | -21.88 Billion | 3.66 Billion | -567.6 Million | -1.7 Billion | 171.35 Million | 2.03 Billion |
| Cash at beginning of period | 30.26 Billion | 21.62 Billion | 13.27 Billion | 7.4 Billion | 7.36 Billion | 8.23 Billion |
| Cash at end of period | 16.2 Billion | 30.26 Billion | 21.62 Billion | 13.27 Billion | 7.4 Billion | 7.36 Billion |
| Capital Expenditure | -6.1 Billion | -6.58 Billion | -6.8 Billion | -6.4 Billion | -2.35 Billion | -3.23 Billion |
| Effect of forex changes on cash | -14.00 | - | - | - | 10.00 | 270.00 |
| Net cash flow / Change in cash | -14.06 Billion | 8.63 Billion | 8.35 Billion | 5.86 Billion | 42.77 Million | -872.13 Million |
| Free Cash Flow | -10.64 Billion | 5.03 Billion | -1.67 Billion | 4.4 Billion | 3.35 Billion | 168.09 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -487.44 Million | 1.08 Billion | 309.18 Million | 68.88 Million | 6.62 Billion | 1.74 Billion |
| Depreciation & Amortization | 976.28 Million | 864.35 Million | 865.7 Million | 809.34 Million | 3.3 Billion | 795.97 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -2.59 Billion | -2.89 Billion | -3.53 Billion | -584.97 Million | -28.23 Billion | -5.18 Billion |
| Other non-cash items | 470.3 Million | 64.88 Million | 8.57 Billion | -934.92 Million | 13.76 Billion | 165.87 Million |
| Investing Cash Flow | -646.01 Million | -5.12 Billion | -937.55 Million | 1.44 Billion | -3.08 Billion | -2.77 Billion |
| Investments in PPE | -5.84 Billion | -1.09 Billion | -2.07 Billion | -1.26 Billion | -6.1 Billion | -1.66 Billion |
| Acquisitions | 5.5 Million | - | 5.45 Million | 5.55 Billion | 793.11 Million | - |
| Investment purchases | -158.04 Thousand | -5 Billion | -11.11 Million | -3.47 Billion | -3.97 Billion | - |
| Sales/Maturities of investments | 5.05 Billion | 906.22 Million | 1.15 Billion | 724.06 Million | 4.49 Billion | 1.97 Billion |
| Other Investing Activities | -40.21 Million | 70.46 Million | -9.36 Million | -96.54 Million | 1.7 Billion | -3.09 Billion |
| Financing Cash Flow | 856.87 Million | 1.71 Billion | -1.3 Billion | -1.07 Billion | -6.42 Billion | -1.43 Billion |
| Debt repayment | -966 Million | -3.7 Billion | - | - | -8 Billion | - |
| Dividends payments | - | -923.12 Million | - | -3680.00 | -826.19 Million | - |
| Common Stock Repurchased | - | -906.22 Million | -1.15 Billion | -724.06 Million | -3.8 Billion | -1.28 Billion |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -109.12 Million | -153.21 Million | 10.00 | -348.98 Million | 6.2 Billion | -150.58 Million |
| Accounts receivables | -3.03 Billion | -103.71 Million | 1.14 Billion | 1.9 Billion | 3 Billion | 177.29 Million |
| Accounts payables | -4.41 Billion | 2.99 Billion | 857.37 Million | -1.49 Billion | -6.2 Billion | -6.78 Billion |
| Inventory | 5.62 Billion | -397.33 Million | -7.78 Billion | 3.62 Billion | -3.14 Billion | 176.32 Million |
| Other working capital | -5.18 Billion | -5.39 Billion | 2.24 Billion | -4.6 Billion | -21.88 Billion | 1.24 Billion |
| Cash at beginning of period | 9.13 Billion | 12.66 Billion | 16.2 Billion | 16.47 Billion | 30.26 Billion | 23.15 Billion |
| Cash at end of period | 7.71 Billion | 9.13 Billion | 12.66 Billion | 16.2 Billion | 16.2 Billion | 16.47 Billion |
| Capital Expenditure | -5.84 Billion | -1.09 Billion | -2.07 Billion | -1.26 Billion | -6.1 Billion | -1.66 Billion |
| Effect of forex changes on cash | - | - | - | -20.00 | -14.00 | - |
| Net cash flow / Change in cash | -1.42 Billion | -3.52 Billion | -3.53 Billion | -267.21 Million | -14.06 Billion | -6.68 Billion |
| Free Cash Flow | -7.48 Billion | -1.21 Billion | -3.37 Billion | -1.9 Billion | -10.64 Billion | -4.14 Billion |
DGX
RYAOF
DHATRE
SXOOF
CSRA
NTGR